Dr. Robert Sargis, MD

• Endocrinology, Diabetes & Metabolism

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• The University Of Chicago Medical Center

  Fellowship Hospital, 2010

• The University Of Chicago Medical Center

  Residency Hospital, 2007

• The University Of Chicago Medical Center

  Internship Hospital, 2006

• Rush Medical College

  Medical School, 2005

• Tributyltin Differentially Promotes Development of a Phenotypically Distinct Adipocyte, 2015-08-04

• THE DIABETES EPIDEMIC Environmental Chemical Exposure in Etiology and Treatment, 2013-05-16

• Environmental Endocrine Disruptors Promote Adipogenesis in the 3T3-L1 Cell Line through Glucocorticoid Receptor Activation, 2009-11-19

• Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-Small Cell Lung Cancer, 2014-04-26

• Metabolic disruption in context: Clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals, 2015-08-19

• Environmental Endocrine Disruption of Energy Metabolism and Cardiovascular Risk, 2014-05-22

• Physician perspectives on de-intensifying diabetes medications, 2016-11-18

• PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor, 2012-05-16

• Adipocytes under Assault: Environmental Disruption of Adipose Physiology, 2013-06-02

• Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis, 2015-08-01

• The Novel Endocrine Disruptor Tolylfluanid Impairs Insulin Signaling in Primary Rodent and Human Adipocytes through a Reduction in Insulin Receptor Substrate-1 Levels, 2012-02-23

• ARSENIC EXPOSURE DECREASES ADIPOSITY DURING HIGH-FAT FEEDING, 2020-03-20